Stone House Investment Management »

Gt Biopharma shares owned by Stone House Investment Management

Quarter-by-quarter ownership of Gt Biopharma (GTBP) shares owned by Stone House Investment Management from 13F filings

Historical chart of Stone House Investment Management investment in Gt Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Gt Biopharma held by Stone House Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gt Biopharma by Stone House Investment Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $510 1.3k 0.41

More positions owned by Stone House Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Univrsl Usd (IUSB)
Ishares Tr S&p 500 Val Etf (IVE)
Ishares Tr S&p 500 Grwt Etf (IVW)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Ishares Core Msci Emkt (IEMG)
Procter & Gamble Company (PG)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr 10-20 Yr Trs Etf (TLH)
Ishares Tr Eafe Grwth Etf (EFG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Fidelity Covington Trust Enhanced Intl (FENI)
Blackrock Etf Trust Ishares A I Inno (BAI)
Ishares Tr Msci Usa Mmentm (MTUM)

View all positions for Stone House Investment Management

Top funds holding Gt Biopharma

Vanguard Capital Management
Geode Capital Management
Vanguard Fiduciary Trust
SRS Capital Advisors
Citadel Advisors
SeaCrest Wealth Management
UBS Group
Two Sigma Securities
LPL Financial
Invst
Advisor Group Holdings
Keel Point
HPM Partners
Integrated Wealth Concepts
Private Wealth Management Group

View all funds holding Gt Biopharma